Search Results 241-250 of 14775 for anti-TNF drugs

1. Interferon Alfa-2b (Injection Route) Side Effects - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Antidepressants: Get tips to cope with side effects - Mayo Clinic

   If insomnia is an ongoing problem, ask your doctor about taking a sedating medication at bedtime or ask whether taking a low dose of a sedating antidepressant ...

3. Infliximab-Qbtx (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Dolutegravir (Oral Route) Description and Brand Names - Mayo Clinic

   ... anti-HIV medicines in the past or to replace their current anti-HIV medicines. HIV is the virus that causes acquired immune deficiency syndrome (AIDS) ...

5. A Study to Evaluate Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis - Mayo Clinic

   Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, anti-TNF, and anti-integrin therapy are permitted. To meet the ...

6. Cyclophosphamide (Oral Route, Intravenous Route) Before Using - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

7. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma · Overview · Participation ...

8. Fluconazole (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors - Mayo Clinic

   An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid ...

10. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... Subjects have received anti-TNF treatment within 60 days before baseline (Visit 2).